The Food and Drug Administration is expected to announce the decision after a two-year review of data from Juul.
And it could take up to a year for the FDA to craft the rule’s language. Juul has been in the spotlight for four years and was one of the first e-cigarette companies to come under fire. But there has been little rigorous study of whether the e-cigarettes truly help smokers quit.
Juul had submitted an application to the FDA almost two years ago asking the agency to allow its menthol and tobacco-flavored products to remain on the ...
The plunge came as the FDA set its sights on tackling the youth vaping epidemic and after the company faced a host of lawsuits for its marketing strategies. The reviews were part of a larger effort by the FDA to increase its regulation of tobacco products after a burst of e-cigarette sales, fueled in large part by the introduction of Juul’s vaping device in 2015 that appealed to teeangers, especially those who had never smoked before. The move comes three years after Juul—in an effort to remake its public image after being blamed for causing a spike in underage vaping—stopped selling certain flavors of e-cigarettes, including sweet and fruity products, and backed off its marketing.
In 2019, the company ended sales of its flavored products in the United States. That move came shortly before the FDA banned all vaping flavors except tobacco ...
, which sells Marlboro, Virginia Slims and Parliament cigarettes in the United States, announced in 2020 that it took a $4.1 billion charge related to its Juul investment. The FDA hasn't formally announced a move as of yet, and CNN has been unable to verify the Journal's report The company invested $12.8 billion for a 35% stake in Juul in 2018.
In October, the FDA had allowed a Juul rival, British American Tobacco, to market its Vuse Solo e-cigarettes and tobacco-flavored pods, the first vapor product ...
In October, the FDA had allowed a Juul rival, British American Tobacco, to market its Vuse Solo e-cigarettes and tobacco-flavored pods, the first vapor product to get clearance from the health regulator. Shares in the tobacco giant Altria Group, which owns a 35% stake in the maker of vaping products, fell 8.5% following the report. “This clearly comes as a surprise to the market … we would expect that Juul would appeal the decision, and remain on the market through that process, which would likely take a year or more,” said Vivien Azer, an analyst with Cowen.
The U.S. Food and Drug Administration is preparing to order Juul Labs Inc to take its e-cigarettes off the market in the United States, the Wall Street ...
Register now for FREE unlimited access to Reuters.com Register now for FREE unlimited access to Reuters.com Shares in tobacco giant Altria Group (MO.N), which owns a 35% stake in the vaping products maker, fell 8.5% following the report. Register now for FREE unlimited access to Reuters.com
The US Food and Drug Administration is getting ready to order Juul Labs Inc.'s e-cigarettes off the market, the Wall Street Journal reported, citing people ...
The Biden administration has already made moves on menthol cigs and curbing nicotine, and now it's complicating its plans with a run against the e-cig ...
The Centers for Disease Control has repeatedly said that any vaping product is bad for your health, though the federal government has struggled to define the distinctions between the vaping devices and the substances people inhale. So the government’s own research suggests there’s a need for e-cigarette products to help people quit the habit. Just yesterday, the Washington Post reported that Biden’s team is expected to require companies to cut back the amount of nicotine found in cigarettes. The Joe Biden administration seems to have no such compunctions. The news comes after multiple controversies related to whether Juul and other e-cigarette manufacturers were marketing their sweet-flavored pods to young children through advertising. The hammer-blow decision would likely hemorrhage the already staggering vape company after it stopped selling flavors back in 2019, shortly before the FDA banned fruity e-cigarette flavor pods in early 2020.
Juul gained notoriety after it was criticized for selling flavored vape pods that were popular with teens. Advertisement. The company ended sales of its ...
The company ended sales of its flavored products in 2019, shortly before the FDA banned the products. The agency has not formally announced a move yet, but according to the Journal, the order could come as soon as Wednesday. The Wall Street Journal is reporting that the Food and Drug Administration could order the e-cigarette maker to pull its products from store shelves.
The U.S. Food and Drug Administration is reportedly preparing an order to remove Juul Labs vaping products from the market.
"Juul is largely responsible for the youth vaping epidemic," Sward said. The study is ongoing, but some have kicked the habit by switching to e-cigarettes, he said. In 2020, the FDA required all e-cigarette and vaping companies to submit applications to continue marketing products.
Anti-smoking advocates said they are cautiously optimistic following a report that the Food and Drug Administration (FDA) is preparing to remove Juul's ...
We invite you to join the discussion on Facebook and Twitter. Juul took its fruit- and mint-flavored nicotine pods off the market in 2019. “Juul, more than any other product and any other company, has been responsible for creating and fueling the youth e-cigarette epidemic. But the move has not paid off. Tobacco giant Altria, which sells Marlboro, Virginia Slims and Parliament cigarettes in the United States, invested $12.8 billion for a 35 percent stake in Juul in 2018. The agency has been reviewing applications from manufacturers ever since.
Brand-loyal vapers are flocking to their favorite shops to stock up on Juul Labs Inc.'s e-cigarettes, amid news that the products could soon be taken off the ...
Juul gained notoriety after it was criticized for selling flavored vape pods that were popular with teens. Advertisement. The company ended sales of its ...
The company ended sales of its flavored products in 2019, shortly before the FDA banned the products. The agency has not formally announced a move yet, but according to the Journal, the order could come as soon as Wednesday. The Wall Street Journal is reporting that the Food and Drug Administration could order the e-cigarette maker to pull its products from store shelves.
It's almost Shakespearean. Juul, the e-cigarette company that took the U.S. by storm five years ago — and which was valued at its peak at $38 billion — is ...
You can select 'Manage settings' for more information and to manage your choices. You can change your choices at any time by visiting Your Privacy Controls. Find out more about how we use your information in our Privacy Policy and Cookie Policy. Click here to find out more about our partners. - Information about your device and internet connection, including your IP address
The US FDA may be preparing to ban the e-cigarette maker. That would be a blow to tobacco giant Altria, which owns a 35% stake.
The approval of Vuse Alto could also go either way. The company is also buying Swedish Match AB, maker of trendy nicotine pouches for $16 billion. However, it is still awaiting the FDA decision on its main product, the Vuse Alto. The potential decision on Juul is a risk for BAT, too. Some of BAT’s Vuse vape models, now the leader in US vapor, have already been approved. It has progressively written down the value, and the worth of the brand most recently stood at $1.6 billion. But if Vuse Alto is permitted to stay in the US market and Juul is not, that would be a boon for BAT. It’s also worth contrasting the FDA’s stance with that of the British government, which sees e-cigarettes as a way to help people quit smoking.
Joe Biden pressed forward on the Juul ban after a two-year federal study, which showed vapes are capital B-Bad.
We can only hope that these vape fiends will grow up and smoke a cigarette; the more likely scenario is they will try to ban my kind from that South Carolina courtyard. Fifteen years after lawmakers ruined every bar and diner in America in the name of science, researchers revisited the findings only to discover they were illegitimate. Who is this guy in the blue jacket and red stripes in his slacks, and why is he trying to get me to board a helicopter? How else to explain the April announcement to ban menthols and the administration’s embrace of Trump’s biggest administrative legacy: eliminating nicotine in cigarettes? Those shades came from manicured hands holding glorified USB memory sticks, the fingers stained yellow by 70-millimeter Marlboros. I gathered with the only people holding the latter — a bar manager and pair of fathers no doubt looking to calm the nerves after realizing this is... Those shades came from manicured hands holding glorified USB memory sticks, the fingers stained yellow by 70-millimeter Marlboros. I gathered with the only people holding the latter — a bar manager and pair of fathers no doubt looking to calm the nerves after realizing this is what they took out a second mortgage to pay for.
Team Biden goes after e-cigarettes and nicotine, as if it had nothing else to do.
You may cancel your subscription at anytime by calling Customer Service. The 1998 state settlement helped the Big Four Tobacco companies grow profits and cement their market share, as our columnist Holman Jenkins has noted. The Biden Administration’s instinct is always to shoot business first and clean up the unintended consequences later.
FDA may toss Juul e-cigs from store shelves · Juul did not respond to emailed request for comment. · Groups that oppose youth smoking say taking the company off ...
And they fault today's decision-makers for downplaying the issues that move them, like school shootings and racism. - A court ordered the FDA to make decisions by September 2021. They crave work-life balance and mental health support. What's next: The FDA still has many products to review and a bipartisan group of lawmakers in Congress is calling on the agency to expedite the process and take aim at addictive products marketed towards teens. - E-cigarette industry groups are calling on the FDA to go after bad actors that are skirting the review process. - Now, all e-cigarette manufacturers have to show products are "appropriate for the protection of public health," per the FDA.
The FDA has cleared the way for Juul's biggest rivals to keep tobacco-flavored e-cigarettes on the market, but a similar approval might not happen for Juul.
Juul asked to continue selling its tobacco- and menthol-flavored products in 3 percent and 5 percent nicotine strengths. Its appeal to young people, which has raised concerns of reversing long-term declines in the number of youths picking up smoking, is what first got the company into trouble with the FDA. Newsweek has contacted the FDA and Juul for comment. The news was reported by The Wall Street Journal on Wednesday, which cited people familiar with the matter as its sources. Since then, the company has been trying to adapt to the closer scrutiny of regulators and the public, stopping the sale of sweet and fruity flavors in 2019 and voluntarily shutting down its The Food and Drug Administration ( FDA) is set to take Juul e-cigarettes off the market in the U.S., three years after the company stopped selling its fruity and sweet flavors after being accused of targeting minors.
WEDNESDAY, June 22, 2022 (HealthDay News) -- The U.S. Food and Drug Administration is poised to pull Juul Lab e-cigarettes off the American market.
The company stopped selling its fruity and sweet flavors in 2019. In response, the company stopped using models, suspended all advertising in the United States, and shut down its Facebook and Instagram accounts. Regulators have since been reviewing thousands of applications for vaping products after tightening their oversight of the electronic cigarette market.
Team Biden goes after e-cigarettes and nicotine, as if it had nothing else to do.
You may cancel your subscription at anytime by calling Customer Service. The 1998 state settlement helped the Big Four Tobacco companies grow profits and cement their market share, as our columnist Holman Jenkins has noted. The Biden Administration’s instinct is always to shoot business first and clean up the unintended consequences later.
The Food and Drug Administration rejected Juul's application to sell its e-cigarettes in the U.S..
The FDA gained the power to regulate new tobacco products in 2009. The FDA said it didn't see clinical information that suggests there is an immediate risk to using Juul products. A court decision created a timeline for the FDA's approval process of e-cigarette company's premarket tobacco product applications. Nicotine is the ingredient that makes tobacco addictive, and it may have other negative health effects. The FDA has been making strides to cut down nicotine use in traditional tobacco products, too. The agency said it approved both companies' tobacco-flavored products because they proved they could benefit adult smokers and outweighed the risk to underage users. As of March, Altria valued its stake at $1.6 billion, an eighth of its original investment, and Juul itself at under $5 billion. It has already settled with North Carolina for $40 million and Washington state for $22.5 million. Still, as a result of Thursday's decision, Juul must stop selling and distributing its products in the U.S. effective immediately. An outbreak of vaping-related lung disease in 2020 heightened concerns about e-cigarettes. The flavors were not subject to a 2020 agency ban on mint- and fruit-flavored vaping products that were popular with teens. Juul's international expansion efforts have been hamstrung by regulations and a lack of consumer interest.
Today, the U.S. Food and Drug Administration issued marketing denial orders (MDOs) to JUUL Labs Inc. for all of their products currently marketed in the ...
The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products. In addition to ensuring that JUUL complies with this order, as with unauthorized products generally, the FDA intends to ensure compliance by distributors and retailers. To date, the FDA has not received clinical information to suggest an immediate hazard associated with the use of the JUUL device or JUULpods. However, the MDOs issued today reflect FDA’s determination that there is insufficient evidence to assess the potential toxicological risks of using the JUUL products. As the FDA has stated in the past, unauthorized electronic nicotine delivery system (ENDS) products for which no application is pending, including for example, those with an MDO, are among our highest enforcement priorities. In particular, some of the company’s study findings raised concerns due to insufficient and conflicting data – including regarding genotoxicity and potentially harmful chemicals leaching from the company’s proprietary e-liquid pods – that have not been adequately addressed and precluded the FDA from completing a full toxicological risk assessment of the products named in the company’s applications. The products include the JUUL device and four types of JUULpods: Virginia tobacco flavored pods at nicotine concentrations of 5.0% and 3.0% and menthol flavored pods at nicotine concentrations of 5.0% and 3.0%. Retailers should contact JUUL with any questions about products in their inventory.
The company "will finally be held accountable for creating the youth vaping epidemic," the advocacy group Parents Against Vaping e-cigarettes told NPR.
You may click on “Your Choices” below to learn about and use cookie management tools to limit use of cookies when you visit NPR’s sites. If you click “Agree and Continue” below, you acknowledge that your cookie choices in those tools will be respected and that you otherwise agree to the use of cookies on NPR’s sites. NPR’s sites use cookies, similar tracking and storage technologies, and information about the device you use to access our sites (together, “cookies”) to enhance your viewing, listening and user experience, personalize content, personalize messages from NPR’s sponsors, provide social media features, and analyze NPR’s traffic.
The US Food and Drug Administration ordered Juul products removed from the US market as the agency issued marketing denial orders for its vaping devices and ...
Without the data needed to determine relevant health risks, the FDA is issuing these marketing denial orders." "As a result, the company must stop selling and distributing these products. "The FDA is tasked with ensuring that tobacco products sold in this country meet the standard set by the law, but the responsibility to demonstrate that a product meets those standards ultimately falls on the shoulders of the company," said Michele Mital, acting director of the FDA's Center for Tobacco Products, in the news release.
The agency ruled against the company's application to stay on the market, a decisive blow to a once-popular vaping brand that appealed to teenagers.
In its review of devices that it compared with traditional cigarettes, the agency said that the devices contained a “significant reduction” in harmful chemicals, although some were still present. One hopes Juul can respond effectively to the request for more scientific analysis, make any product adjustments that may be called for, and again offer their products to adults in need.” But the news delivers a significant blow to Altria, formerly known as Philip Morris and the maker of Marlboro, which in December 2018 bought 35 percent of Juul for $12.8 billion. In October, it authorized R.J. Reynolds to continue marketing Vuse. This was the first time the agency granted approval to a vaping product made by a big cigarette company. It now has slightly over 1,000, mostly in the United States, but with some in Canada, Britain and other countries. The adolescent brain is particularly susceptible to nicotine, which can affect memory, concentration, learning and self-control. Juul, in particular, had been the target of regulators, schools and policymakers for years, starting in 2018, when the F.D.A. began an investigation into Juul’s marketing efforts. The news is somewhat less weighty for the industry now than it would have been in Juul’s heyday, given the company’s plummeting market share. In April, the F.D.A. said it would move toward a ban on menthol-flavored cigarettes. In one settlement in 2021, Juul agreed to pay $40 million to North Carolina, which represented various parties in the state who asserted the company had helped lure underage users to vaping. “Today’s action is further progress on the F.D.A.’s commitment to ensuring that all e-cigarette and electronic nicotine delivery system products currently being marketed to consumers meet our public health standards,” Dr. Robert M. Califf, the agency commissioner, said in a statement. “The agency has dedicated significant resources to review products from the companies that account for most of the U.S. market.
In 2021, FDA removed thousands of electronic cigarettes off U.S. shelves but delayed its decision on Juul.
Juul has also faced scrutiny from regulators, public health officials, and lawmakers over its products. Worth noting: The decision comes as the FDA announced plans for a proposed product standard that would decide on maximum nicotine to level to reduce the addictiveness of cigarettes and other tobacco products. The company halted U.S. sales for several of its flavors back in 2019 due to pressure from critics who said the product was being targeted at minors, Reuters reports. - The FDA based its review of the applications on whether e-cigarettes are effective in getting smokers to quit and, if so, whether the benefits to smokers outweigh the health damage to new users, including teenagers. The decision deals a blow to Altria, which in 2018 paid $12.8 billion for a 35% stake in Juul. The big picture: The decision follows a nearly two-year review by the FDA of Juul's data as the vaping company sought authorization for its products to stay on the U.S. market, according to the Wall Street Journal.
Juul, the once-booming Silicon Valley start-up widely blamed for igniting the youth vaping epidemic, was grounded Thursday by federal regulators who ordered ...
The FDA has said it has made substantial progress in plowing through millions of applications but that it has limited resources and would not finish reviewing applications until July 2023. It also could sue the FDA in federal appeals court and seek a stay pending the outcome of the case. About 7.6 percent of middle school and high school students in the 2021 survey said they had used an e-cigarette at least once in the past 30 days, compared with 20 percent in 2019. In 2019, Juul, faced with lawsuits and investigations, announced a “reset” designed to regain the trust of the public and regulators and took several steps to prevent teenagers from buying its products. Still, the FDA said, e-cigarette use remains a concern because more than 2 million middle and high school students reported vaping within the past 30 days. But others said the agency is permitted only to consider a company’s applications, not its previous behavior. In 2020, concerned about youth vaping, the FDA prohibited sales of sweet and fruity e-cigarette pods, which Juul had already stopped selling. That flavor is not popular among young people and the agency has given the green light to other companies to sell tobacco-flavored vapes. In response, the company ultimately took all of its flavored pre-filled pods — except for tobacco and menthol — off the market. During the past several months, the agency has ruled on applications involving millions of e-cigarette products. Juul’s problems with the agency began in 2018, when data showed a huge increase in teenage vaping, fueling a backlash from regulators. But it also prompted a fierce backlash from parents and regulators, who blamed the company for igniting a surge in teenage vaping.
The FDA's Center for Tobacco Products reviewed Juul's applications for its menthol and tobacco-flavored vapes with 3 and 5 percent nicotine pods. Regulators ...
“Juul, more than any other product and any other company, has been responsible for creating and fueling the youth e-cigarette epidemic,” said Matthew Myers, president of the Campaign for Tobacco-Free Kids, in a statement. “This would be the most significant action the FDA has taken to date to end the youth e-cigarette epidemic and stop tobacco companies from using these nicotine-loaded products to addict another generation of kids.” “Winnowing the market down in ways that may limit access or appeal … is a concern.” “As a public health person … all I’m concerned about is that that affects millions of people,” he said. The FDA’s Center for Tobacco Products reviewed Juul’s applications for its menthol and tobacco-flavored vapes with 3 and 5 percent nicotine pods. The company rose to infamy among public health experts as one of the brands responsible for getting teenagers hooked on e-cigarettes in 2018 and 2019 as youth vaping rates ballooned.
The U.S. Food and Drug Administration on Thursday announced a nationwide ban on the sale and marketing of Juul Labs Inc. vaping and e-cigarette products.
"Juul is largely responsible for the youth vaping epidemic," Sward said. In 2020, the FDA required all e-cigarette and vaping companies to submit applications to continue marketing products. The federal agency cited "insufficient and conflicting" data in Juul's application to continue selling non-fruit-flavored products.
Ordena el cese de la venta y distibución de sus dispositivos y de todos sus cargadores de nicotina en ese mercado.
Sin los datos necesarios para determinar los riesgos para la salud, la FDA tiene que expedir esta orden de rechazo", añade. En España empezó a vender sus productos en marzo de 2019, pero su aventura apenas duró un año. La agencia estadounidense ha rechazado todas las solicitudes remitidas por Juul para obtener la autorización definitiva para la comercialización de sus productos.
La FDA culpó a la compañía Juul de contribuir al aumento de vapeo entre los menores de edad en EEUU.
La FDA señaló que Juul puede haber jugado un papel "desproporcionado" en el aumento del vapeo entre menores y no tenía suficiente evidencia para demostrar que comercializar sus productos "sería apropiado para la protección de la salud pública". Pero los actores de la industria y los defensores de la lucha contra el tabaco se han quejado de que esos productos representan solo un pequeño porcentaje del mercado de vapeo de $ 6,000 millones en los EEUU. WASHINGTON — La FDA ordenó a Juul que deje de vender y retire sus cigarrillos electrónicos del mercado estadounidense, convirtiéndose en el golpe más reciente para la asediada compañía a la que se culpa ampliamente de provocar un aumento nacional en el vapeo entre adolescentes.
Health officials have ordered vaping company Juul to pull its electronic cigarettes from the U.S. market.
The brainchild of two Stanford University students, Juul launched in 2015 and within two years rocketed to the top of the vaping market. On Tuesday, the FDA also laid out plans to establish a maximum nicotine level for certain tobacco products to reduce their addictiveness. The next year, the FDA limited flavors in small vaping devices to just tobacco and menthol. Still, federal officials cautioned about interpreting the results given they were collected online for the first time, instead of in classrooms. Separately, Congress raised the purchase age for all tobacco and vaping products to 21. The agency said Thursday that Juul’s application didn’t have enough evidence to show that marketing its products “would be appropriate for the protection of the public health.” But all but the largest e-cigarette manufacturers have resisted conducting that kind of expensive, time-consuming research. In a statement, the FDA said Juul’s application left regulators with significant questions and didn’t include enough information to evaluate any potential risks. The FDA said Juul must stop selling its vaping device and its tobacco and menthol flavored cartridges. The vaping issue took on new urgency in 2018 when Juul’s high-nicotine, fruity-flavored cartridges quickly became a nationwide craze among middle and high school students. Last year’s survey showed Juul was the fourth most popular e-cigarette among high schoolers who regularly vape. To stay on the market, companies must show that their e-cigarettes benefit public health.
Nueva York (CNN Business) -- Un informe que dice que la Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés) podría ordenar a Juul que ...
Las acciones de Altria cayeron un 8% este miércoles mientras que la caída este año ha sido del 13%. La compañía invirtió US$ 12.800 millones por una participación del 35% en Juul en 2018. La FDA aún no ha anunciado formalmente una medida y CNN no ha podido verificar el informe del Journal. Un portavoz de la FDA le dijo a CNN que la agencia no podía proporcionar ninguna información en este momento. La compañía de cigarrillos posee una participación del 35% en Juul. The Wall Street Journal informó este miércoles que la FDA podría ordenar al fabricante de cigarrillos electrónicos que retire sus productos el miércoles luego de una revisión de varios años de la marca con respecto a las preocupaciones de que podría haber ayudado a impulsar la popularidad del vapeo entre los usuarios menores de edad. Nueva York (CNN Business) -- Un informe que dice que la Administración de Alimentos y Medicamentos (FDA, por sus siglas en inglés) podría ordenar a Juul que retire sus productos de los estantes de las tiendas ha hecho que las acciones de Altria se desplomen.
JUUL es una de las principales comercializadoras vapers. Recientemente estuvo bajo el escrutinio público por su papel en la crisis de tabaco.
- La FDA también dijo que la reducción de los niveles de nicotina disminuiría el número de personas que adquieren el hábito. Recientemente se anunció una medida sobre loscigarrillos mentolados. La Administración de Alimentos y Medicamentos (FDA) ordenó la retirada del mercado estadounidense de los vapers JUUL, debido a la sospecha de que haya inducido la crisis del vapeo entre los jóvenes.
La FDA culpó a la compañía Juul de contribuir al aumento de vapeo entre los menores de edad en EEUU.
La FDA señaló que Juul puede haber jugado un papel "desproporcionado" en el aumento del vapeo entre menores y no tenía suficiente evidencia para demostrar que comercializar sus productos "sería apropiado para la protección de la salud pública". Pero los actores de la industria y los defensores de la lucha contra el tabaco se han quejado de que esos productos representan solo un pequeño porcentaje del mercado de vapeo de $ 6,000 millones en los EEUU. WASHINGTON — La FDA ordenó a Juul que deje de vender y retire sus cigarrillos electrónicos del mercado estadounidense, convirtiéndose en el golpe más reciente para la asediada compañía a la que se culpa ampliamente de provocar un aumento nacional en el vapeo entre adolescentes.
The FDA is pulling Juul products off the market, citing “potentially harmful chemicals leaching from the company's proprietary e-liquid pods”
The FDA decided in April, for example, to allow the company NJOY to continue selling its tobacco-flavored products. A yearly survey of youth tobacco users conducted by the Centers for Disease Control and Prevention has found that Juul’s popularity among young people has waned in recent years. “In our applications, which we submitted over two years ago, we believe that we appropriately characterized the toxicological profile of JUUL products, including comparisons to combustible cigarettes and other vapor products.”
La Administración de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en inglés) prohibió la venta de todos los productos de la marca Juul, ...
El líquido y el vapor contienen algunos químicos potencialmente dañinos que también se encuentran en el humo del cigarrillo, pero en niveles mucho más bajos", informa el NHS. Las restricciones internacionales también han limitado su expansión fuera de EE.UU. Más allá de las dudosas prácticas de marketing que haya podido llevar a cabo la empresa, la prohibición de los productos de Juul es una mala noticia para los expertos en salud que creen que los cigarrillos electrónicos son efectivos apara ayudar a dejar los cigarrillos tradicionales, que consideran mucho más nocivos. En su declaración de este jueves, la FDA dijo que no había recibido ninguna información que sugiriera un "peligro inmediato". Pero también destacó la relevancia que los productos de Juul tienen en el mercado de los cigarrillos electrónicos. "La acción de hoy es un avance adicional en el compromiso de la FDA de garantizar que todos los productos de cigarrillos electrónicos y sistemas electrónicos de suministro de nicotina que se comercializan actualmente cumplan con nuestros estándares de salud pública", dijo el comisionado de la FDA, Robert M. Califf, en un comunicado. Al anunciar la medida, la FDA dijo que no tenía suficientes datos para asegurarse de que la comercialización de los productos de la empresa fuera "apropiada para la protección de la salud pública".
La Administración de Medicamentos y Alimentos (FDA) de Estados Unidos anunció el jueves el retiro del mercado de los cigarrillos electrónicos de Juul Labs ...
Los productos de Juul "existen sólo para que los fumadores adultos hagan la transición desde los cigarrillos combustibles", aseguró el presidente ejecutivo, KC Crosthwaite, en el sitio web de la compañía, agregando que se está "trabajando duro" para reconstruir su reputación luego de una "erosión de confianza en los últimos años". Se responsabilizó a Juul por un aumento en el hábito de vapeo a nivel juvenil por su comercialización de cigarrillos electrónicos con sabores frutados y dulces, los cuales dejó de vender en 2019. Esta medida "es un avance adicional en el compromiso de la FDA para garantizar que todos los productos de cigarrillos electrónicos y sistemas electrónicos de suministro de nicotina que se comercializan actualmente (...) cumplan con nuestros estándares de salud pública", dijo el comisionado de la entidad, Robert Califf, en un comunicado.
(CNN) -- La Administración de Alimentos y Medicamentos de Estados Unidos (FDA) ordenó retirar los productos Juul del mercado estadounidense, al tiempo que ...
Seguimos comprometidos a hacer todo lo que esté en nuestra mano para seguir sirviendo a los millones de fumadores adultos estadounidenses que han utilizado con éxito nuestros productos para abandonar los cigarrillos de combustión, que siguen estando disponibles en los estantes del mercado en todo el país", dijo Joe Murillo, director de regulación de Juul Labs, en una declaración a CNN. La compañía dijo que buscará una suspensión y considerará una apelación. Sin los datos necesarios para determinar los riesgos relevantes para la salud, la FDA está emitiendo estas órdenes de denegación de comercialización", agregó.
La agencia reguladora rechazó los documentos presentados por la compañía, que comercializa sólo dispositivos de vapeo de sabor tabaco y mentol.
Sin embargo, Altria ha recortado el valor de la inversión a medida que Juul y la industria de cigarrillos electrónicos en general se vieron envueltas en una controversia. Ya llegó a un acuerdo con Carolina del Norte por 40 millones de dólares y con el estado de Washington por 22,5 millones de dólares, informó CNBC. Los cigarrillos electrónicos contienen nicotina, que es absorbida por los usuarios al vaporizar líquido en cartuchos o cápsulas. La nicotina es el ingrediente que hace que el tabaco sea adictivo y puede tener otros efectos negativos para la salud. Qué dijo la joven que declaró en las últimas horas En 2020, las autoridades de salud registraron un brote de enfermedad pulmonar relacionada con el vapeo, lo que aumentó las preocupaciones sobre los cigarrillos electrónicos. El martes último anunció que planea exigir a las compañías tabacaleras que reduzcan el contenido de nicotina en los cigarrillos a niveles mínimamente adictivos o no adictivos.